This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Oct 1;81(14):1186-8.

doi: 10.1212/WNL.0b013e3182a6cc23. Epub 2013 Aug 30.

AQP4 antibody serostatus: Is its luster being lost in the management and pathogenesis of NMO?

Kazuo Fujihara¹, Douglas Kazutoshi Sato

Affiliations

PMID: 23997154
DOI: 10.1212/WNL.0b013e3182a6cc23

Editorial

AQP4 antibody serostatus: Is its luster being lost in the management and pathogenesis of NMO?

Kazuo Fujihara et al. Neurology. 2013.

. 2013 Oct 1;81(14):1186-8.

doi: 10.1212/WNL.0b013e3182a6cc23. Epub 2013 Aug 30.

Authors

Kazuo Fujihara¹, Douglas Kazutoshi Sato

Affiliation

¹ From the Departments of Multiple Sclerosis Therapeutics (K.F.) and Neurology (K.F., D.K.S.), Tohoku University Graduate School of Medicine, Sendai, Japan.

PMID: 23997154
DOI: 10.1212/WNL.0b013e3182a6cc23

No abstract available

PubMed Disclaimer

Comment on

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Jiao Y, et al. Neurology. 2013 Oct 1;81(14):1197-204. doi: 10.1212/WNL.0b013e3182a6cb5c. Epub 2013 Aug 30. Neurology. 2013. PMID: 23997151 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations